Abstract
Evidence-based toxicology (EBT) was introduced independently by two groups in 2005, in the context of toxicological risk assessment and causation as well as based on parallels between the evaluation of test methods in toxicology and evidence-based assessment of diagnostics tests in medicine. The role model of evidence-based medicine (EBM) motivated both proposals and guided the evolution of EBT, whereas especially systematic reviews and evidence quality assessment attract considerable attention in toxicology.
Regarding test assessment, in the search of solutions for various problems related to validation, such as the imperfectness of the reference standard or the challenge to comprehensively evaluate tests, the field of Diagnostic Test Assessment (DTA) was identified as a potential resource. DTA being an EBM discipline, test method assessment/validation therefore became one of the main drivers spurring the development of EBT.
In the context of pathway-based toxicology, EBT approaches, given their objectivity, transparency and consistency, have been proposed to be used for carrying out a (retrospective) mechanistic validation.
In summary, implementation of more evidence-based approaches may provide the tools necessary to adapt the assessment/validation of toxicological test methods and testing strategies to face the challenges of toxicology in the twenty first century.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adriaens E, Barroso J, Eskes C, Hoffmann S, McNamee P, Alépée N, Bessou-Touya S, De Smedt A, De Wever B, Pfannenbecker U, Tailhardat M, Zuang V (2014) Retrospective analysis of the Draize test for serious eye damage/eye irritation: importance of understanding the in vivo endpoints under UN GHS/EU CLP for the development and evaluation of in vitro test methods. Arch Toxicol 88:701–723
Andersen ME, Al-Zoughool M, Croteau M, Westphal M, Krewski D (2010) The future of toxicity testing. J Toxicol Environ Health B Crit Rev 13:163–196
Balls M, Blaauboer B, Brusick D, Frazier J, Lamb D, Pemberton M, Reinhardt C, Roberfroid M, Rosenkranz H, Schmid B, Spielmann H, Stammati AL, Walum E (1990) Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures. Altern Lab Anim 18:313–337
Birnbaum LS (2013) 15 years out: reinventing ICCVAM. Environ Health Perspect 121:40
Bouhifd M, Andersen ME, Baghdikian C, Boekelheide K, Crofton KM, Fornace AJ Jr, Kleensang A, Li H, Livi CB, Maertens A, McMullen PD, Rosenberg M, Thomas R, Vantangoli M, Yager JD, Zhao L, Hartung T (2015) The human toxome project. ALTEX 32:112–124
Bus JS, Becker RA (2009) Toxicity testing in the 21st century: a view from the chemical industry. Toxicol Sci 112:297–302
Curren RD, Southee JA, Spielmann H, Liebsch M, Fentem JH, Balls M (1995) The role of prevalidation in the development, validation and acceptance of alternative methods. Altern Lab Anim 23:211–217
Eddy DM (2005) Evidence-based medicine: a unified approach. Health Aff 24:9–17
EFSA (European Food Safety Authority) (2010) Application of systematic review methodology to food and feed safety assessments to support decision making. EFSA J 8:1–90
Egger M, Smith GD (1997) Meta-analysis: potentials and promise. BMJ 315:1371–1374
Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315:1533–1537
Eskes C, Hoffmann S, Facchini D, Ulmer R, Wang A, Flego M, Vassallo M, Bufo M, van Vliet E, d’Abrosca F, Wilt N (2014) Validation study on the Ocular Irritection(®) assay for eye irritation testing. Toxicol In Vitro 28:1046–1065
Frazier JM (1994) The role of mechanistic toxicology in test method validation. Toxicol In Vitro 8:787–791
Fung VA, Barrett JC, Huff J (1995) The carcinogenesis bioassay in perspective: application in identifying human cancer hazards. Environ Health Perspect 103:680–683
Griesinger C, Guzelian P (2009) Proceedings of the 1st international forum towards evidence-based toxicology. Hum Exp Toxicol 28:71–163
Guzelian PS, Victoroff MS, Halmes NC, Janes RC, Guzelian CP (2005) Evidence-based toxicology: a comprehensive framework for causation. Hum Exp Toxicol 24:161–201
Hartung T (2010) Evidence-based toxicology - the toolbox of validation for the 21st century? ALTEX 27:253–263
Hartung T, McBride M (2011) Food for thought … on mapping the human toxome. ALTEX 28:83–93
Hartung T, Bremer S, Casati S, Coecke S, Fortaner S, Gribaldo L, Halder M, Hoffmann S, Janusch-Roi A, Prieto P, Sabbioni E, Scott L, Worth A, Zuang V (2004) A modular approach to the ECVAM principles on test validity. Altern Lab Anim 32:467–472
Hartung T, Hoffmann S, Stephens M (2013) Mechanistic validation. ALTEX 30:119–130
Higgins JPT, Green S (eds) (2008) Cochrane handbook for systematic reviews of interventions. Wiley, Chichester (UK)
Hill AB (1965) The environment and disease: association or causation? Proc R Soc Med 58:295–300
Hoffmann S, Hartung T (2005) Diagnosis: toxic! − trying to apply approaches of clinical diagnostics and prevalence in toxicology considerations. Toxicol Sci 85:422–428
Hoffmann S, Hartung T (2006) Toward an evidence-based toxicology. Hum Exp Toxicol 25:497–513
Hoffmann S, Cole T, Hartung T (2005) Skin irritation: prevalence, variability, and regulatory classification of existing in vivo data from industrial chemicals. Regul Toxicol Pharmacol 41:159–166
Hoffmann S, Edler L, Gardner I, Gribaldo L, Hartung T, Klein C, Liebsch M, Sauerland S, Schechtman L, Stammati A, Nikolaidis E (2008a) Points of reference in the validation process. Altern Lab Anim 36:343–352
Hoffmann S, Saliner AG, Patlewicz G, Eskes C, Zuang V, Worth AP (2008b) A feasibility study developing an integrated testing strategy assessing skin irritation potential of chemicals. Toxicol Lett 180:9–20
Horvath AR, Pewsner D (2004) Systematic reviews in laboratory medicine: principles, processes and practical considerations. Clin Chim Acta 342:23–39
Judson R, Kavlock R, Martin M, Reif D, Houck K, Knudsen T, Richard A, Tice RR, Whelan M, Xia M, Huang R, Austin C, Daston G, Hartung T, Fowle JR III, Wooge W, Tong W, Dix D (2013) Perspectives on validation of high-throughput assays supporting 21st century toxicity testing. ALTEX 30:51–56
Krauth D, Woodruff TJ, Bero L (2013) Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environ Health Perspect 121:985–992
Leist M, Hasiwa M, Daneshian M, Hartung T (2012) Validation and quality control of replacement alternatives – current status and future challenges. Toxicol Res 1:8–22
Lucas NP, Macaskill P, Irwig L, Bogduk N (2010) The development of a quality appraisal tool for studies of diagnostic reliability (QAREL). J Clin Epidemiol 63:854–861
Maxim L, van der Sluijs JP (2014) Qualichem in vivo: a tool for assessing the quality of in vivo studies and its application for bisphenol A. PLoS One 9:e87738
NRC (National Research Council) (2007) Toxicity testing in the 21st century: a vision and a strategy. National Academy Press, Washington, DC
NRC (National Research Council) (2014) Review of EPA’s Integrated Risk Information System (IRIS) process. National Academy Press, Washington, DC
OECD (2005) Guidance document on the validation and international acceptance of new or updated test methods for hazard identification. 1-96. Organisation for Economic Cooperation and Development. Environmental Health and Safety Monograph Series on Testing and Assessment No. 34
Reitsma JB, Rutjes AWS, Khan KS, Coomarasamy A, Bossuyt PM (2009) A review of solutions for diagnostic accuracy studies with an imperfect or missing reference standard. J Clin Epidemiol 62:797–806
Rooney AA, Boyles AL, Wolfe MS, Bucher JR, Thayer KA (2014) Systematic review and evidence integration for literature-based environmental health science assessments. Environ Health Perspect 122:711–718
Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS (1996) Evidence based medicine: what it is and what it isn’t. BMJ 312:71–72
Schneider K, Schwarz M, Burkholder I, Kopp-Schneider A, Edler L, Kinsner-Ovaskainen A, Hartung T, Hoffmann S (2009) "ToxRTool", a new tool to assess the reliability of toxicological data. Toxicol Lett 189:138–144
Stephens ML, Andersen M, Becker RA, Betts K, Boekelheide K, Carney E, Chapin R, Devlin D, Fitzpatrick S, Fowle JR III, Harlow P, Hartung T, Hoffmann S, Holsapple M, Jacobs A, Judson R, Naidenko O, Pastoor T, Patlewicz G, Rowan A, Scherer R, Shaikh R, Simon T, Wolf D, Zurlo J (2013) Evidence-based toxicology for the 21st century: opportunities and challenges. ALTEX 30:74–103
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM, QUADAS-2 Group (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hoffmann, S., Hartung, T., Stephens, M. (2016). Evidence-Based Toxicology. In: Eskes, C., Whelan, M. (eds) Validation of Alternative Methods for Toxicity Testing. Advances in Experimental Medicine and Biology, vol 856. Springer, Cham. https://doi.org/10.1007/978-3-319-33826-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-33826-2_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33824-8
Online ISBN: 978-3-319-33826-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)